IL17A and psoriasis: IL-17 signaling plays a major role in setting the inflammatory pathophysiological changes associated with psoriasis with enhanced IL-17-producing T cells and inflamed hyperproliferative keratinocytes in response to amplified IL-17 expression in psoriatic lesions and systemic circulation (63, 78).